ONC — Oncimmune Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- £20.46m
- £22.56m
- £1.15m
Annual cashflow statement for Oncimmune Holdings, fiscal year end - August 31st, GBP millions except per share, conversion factor applied.
2019 May 31st | 2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 August 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | PRESS | PRESS |
| Standards: | IFRS | IFRS | IFRS | — | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -8.55 | -9.78 | -5.7 | -9.53 | 4.33 |
| Depreciation | |||||
| Non-Cash Items | 0.312 | 0.188 | 1.77 | 2.75 | -10.4 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.638 | 0.192 | -1.34 | -0.857 | -1.71 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -7.36 | -8.9 | -4.53 | -6.21 | -6.79 |
| Capital Expenditures | -0.193 | -0.236 | -1.07 | -0.504 | -0.031 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.03 | 0.583 | 0.215 | 0 | 11.6 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.163 | 0.347 | -0.856 | -0.504 | 11.6 |
| Financing Cash Flow Items | -0.07 | 0 | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.07 | 7.46 | 9.78 | 0.987 | -3.02 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -7.59 | -1.12 | 4.39 | -6.1 | 1.78 |